NCT02029612

Brief Summary

The goal of this research study is to compare 2 different phone-based programs for quitting smoking for people with HIV/AIDS.

Trial Health

10
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 19, 2013

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 8, 2014

Completed
3 months until next milestone

Study Start

First participant enrolled

April 1, 2014

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
Last Updated

February 28, 2014

Status Verified

February 1, 2014

Enrollment Period

5 years

First QC Date

November 19, 2013

Last Update Submit

February 27, 2014

Conditions

Keywords

Tobacco Use CessationCancer PreventionHIV/AIDSQuestionnairesSurveysNicotine patchBreath testCell Phone Calls for Smoking Cessation CounselingText Message Smoking Cessation Support

Outcome Measures

Primary Outcomes (1)

  • Smoking Abstinence

    Smoking abstinence defined as biochemically confirmed 7-day abstinence. Expired CO will be used to biochemically verify abstinence.

    3 months

Study Arms (2)

Group 1 - Phone Call Support

OTHER

Smoking cessation telephone hotline phone number provided to participants, along with a 10 week supply of nicotine patches. Each participant counseled on quitting smoking at baseline. Questionnaires completed at baseline, 3 months, and at 6 months. Participant receives 11 phone calls from study staff over a 6-month period. Breath test performed at 3 month and 6 month visit.

Drug: Nicotine PatchBehavioral: Phone CounselingBehavioral: QuestionnairesBehavioral: Breath TestBehavioral: Proactive Cell Phone Smoking Cessation Counseling

Group 2 - Text Messaging Support

OTHER

Participants receive 10 week supply of nicotine patches. Each participant counseled on quitting smoking at baseline. Questionnaires completed at baseline, 3 months, and at 6 months. Participants receive text messages for support about quitting smoking over a 6 month period. Breath test performed at 3 month and 6 month visit.

Drug: Nicotine PatchBehavioral: Phone CounselingBehavioral: QuestionnairesBehavioral: Breath TestBehavioral: Text Message Smoking Cessation Support

Interventions

10 week supply of nicotine patches given to participants at baseline.

Group 1 - Phone Call SupportGroup 2 - Text Messaging Support

Each participant counseled on quitting smoking at baseline.

Group 1 - Phone Call SupportGroup 2 - Text Messaging Support
QuestionnairesBEHAVIORAL

Questionnaires completed at baseline, 3 months, and at 6 months.

Also known as: Surveys
Group 1 - Phone Call SupportGroup 2 - Text Messaging Support
Breath TestBEHAVIORAL

Breath test performed at 3 month and 6 month visit.

Group 1 - Phone Call SupportGroup 2 - Text Messaging Support

Participant receives 11 phone calls from study staff over a 6-month period.

Group 1 - Phone Call Support

Participants receive text messages for support about quitting smoking over a 6 month period.

Group 2 - Text Messaging Support

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Receiving care for HIV/AIDS at a Legacy Community Health Services Clinic
  • years of age or older
  • Self-reported current smoker (smoked at least 100 cigarettes in lifetime and smoking every day or most days)
  • Able to provide written informed consent to participate
  • English or Spanish speaking

You may not qualify if:

  • Positive history of a medical condition that precludes use of the nicotine patch
  • Current use of nicotine replacement therapy (NRT)
  • Current use of other smoking cessation medications (e.g., Chantix or Zyban)
  • Pregnant or nursing
  • Enrolled in another smoking cessation study
  • Unwilling to set a target quit date

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Conditions

Tobacco Use CessationAcquired Immunodeficiency Syndrome

Interventions

Tobacco Use Cessation DevicesSurveys and Questionnaires

Condition Hierarchy (Ancestors)

Health BehaviorBehaviorHIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Damon Vidrine, MS, DRPH, BA

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 19, 2013

First Posted

January 8, 2014

Study Start

April 1, 2014

Primary Completion

April 1, 2019

Last Updated

February 28, 2014

Record last verified: 2014-02